AstraZeneca Sues FDA To Stop Crestor Generics
AstraZeneca Pharmaceuticals LP is suing the U.S. Food and Drug Administration to stop a wave of generic versions of its cholesterol treatment Crestor from hitting the market next month when its...To view the full article, register now.
Already a subscriber? Click here to view full article